Literature DB >> 15247273

Lipoteichoic acid and toll-like receptor 2 internalization and targeting to the Golgi are lipid raft-dependent.

Martha Triantafilou1, Maria Manukyan, Alan Mackie, Siegfried Morath, Thomas Hartung, Holger Heine, Kathy Triantafilou.   

Abstract

Lipoteichoic acid (LTA), a key cell wall component of Gram-positive bacteria, seems to function as an immune activator with characteristics very similar to lipopolysaccharide from Gram-negative bacteria. It has been shown that LTA binds CD14 and triggers activation via Toll-like receptor 2, but whether the activation occurs at the cell surface or internalization is required to trigger signaling has yet to be demonstrated. In this work we have investigated LTA binding and internalization and found that LTA and its receptor molecules accumulate in lipid rafts and are subsequently targeted rapidly to the Golgi apparatus. This internalization seems to be lipid raft-dependent because raft-disrupting drugs inhibited LTA/Toll-like receptor 2 colocalization in the Golgi. Similarly to lipopolysaccharide, LTA activation occurs at the cell surface, and the observed trafficking is independent of signaling. Copyright 2004 American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15247273     DOI: 10.1074/jbc.M400466200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  Molecular mechanisms of TLR2-mediated antigen cross-presentation in dendritic cells.

Authors:  Kuan-Yin Shen; Ying-Chyi Song; I-Hua Chen; Chih-Hsiang Leng; Hsin-Wei Chen; Hui-Ju Li; Pele Chong; Shih-Jen Liu
Journal:  J Immunol       Date:  2014-03-28       Impact factor: 5.422

Review 2.  Toll-like receptors and the eye.

Authors:  Fu-Shin X Yu; Linda D Hazlett
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-04       Impact factor: 4.799

Review 3.  Ca2+ signaling in airway epithelial cells facilitates leukocyte recruitment and transepithelial migration.

Authors:  Jarin Chun; Alice Prince
Journal:  J Leukoc Biol       Date:  2009-07-15       Impact factor: 4.962

4.  Inflammasome-mediated secretion of IL-1β in human monocytes through TLR2 activation; modulation by dietary fatty acids.

Authors:  Ryan G Snodgrass; Shurong Huang; Il-Whan Choi; John C Rutledge; Daniel H Hwang
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

5.  Cellular trafficking of lipoteichoic acid and Toll-like receptor 2 in relation to signaling: role of CD14 and CD36.

Authors:  Nadra J Nilsen; Susanne Deininger; Unni Nonstad; Frode Skjeldal; Harald Husebye; Dmitrii Rodionov; Sonja von Aulock; Thomas Hartung; Egil Lien; Oddmund Bakke; Terje Espevik
Journal:  J Leukoc Biol       Date:  2008-05-05       Impact factor: 4.962

Review 6.  The role of innate immune signaling in the pathogenesis of atopic dermatitis and consequences for treatments.

Authors:  Yuliya Skabytska; Susanne Kaesler; Thomas Volz; Tilo Biedermann
Journal:  Semin Immunopathol       Date:  2015-11-16       Impact factor: 9.623

7.  Lipoteichoic acid is important in innate immune responses to gram-positive bacteria.

Authors:  Ho Seong Seo; Suzanne M Michalek; Moon H Nahm
Journal:  Infect Immun       Date:  2007-10-22       Impact factor: 3.441

8.  Linear and branched glyco-lipopeptide vaccines follow distinct cross-presentation pathways and generate different magnitudes of antitumor immunity.

Authors:  Olivier Renaudet; Gargi Dasgupta; Ilham Bettahi; Alda Shi; Anthony B Nesburn; Pascal Dumy; Lbachir BenMohamed
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

9.  Murine toll-like receptor 2 activation induces type I interferon responses from endolysosomal compartments.

Authors:  Nicole Dietrich; Stefan Lienenklaus; Siegfried Weiss; Nelson O Gekara
Journal:  PLoS One       Date:  2010-04-20       Impact factor: 3.240

10.  No evidence of altered alveolar macrophage polarization, but reduced expression of TLR2, in bronchoalveolar lavage cells in sarcoidosis.

Authors:  Maria Wikén; Farah Idali; Muntasir Abo Al Hayja; Johan Grunewald; Anders Eklund; Jan Wahlström
Journal:  Respir Res       Date:  2010-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.